<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7126206/results/search/test_trace/results.xml">
  <result pre="stages were investigated. Materials and methods A model of HSV-2" exact="infection" post="of VK2/E6E7 was developed. In order to explore JZ-1's"/>
  <result pre="host cell morphologies and increased host cell viabilities observed after" exact="treatment" post="for 24 h. The anti-HSV-2 effect of JZ-1 can"/>
  <result pre="h. The anti-HSV-2 effect of JZ-1 can be detected after" exact="treatment" post="for 6 h while that of penciclovir was not"/>
  <result pre="6 h while that of penciclovir was not obvious until" exact="treatment" post="for 12 h. JZ-1 showed distinct effect on HSV-2"/>
  <result pre="sexual behavior. HSV-2 causes genital herpes or ulcers during acute" exact="infection" post="(Kesharwani et al., 2017, p. 2), and can migrate"/>
  <result pre="and can migrate to cranial ganglia resulting in lifelong latent" exact="infection" post="(Liu et al., 2018). HSV-2 infection during early pregnancy"/>
  <result pre="resulting in lifelong latent infection (Liu et al., 2018). HSV-2" exact="infection" post="during early pregnancy can also cause neonatal encephalitis through"/>
  <result pre="factor for human immunodeficiency virus (HIV) and human papillomavirus (HPV)" exact="infection" post="(Nikolic and Piguet, 2010), and increase the risk of"/>
  <result pre="(Nikolic and Piguet, 2010), and increase the risk of HIV-1" exact="infection" post="by 2–3-fold (Mohraz et al., 2018). The prevention and"/>
  <result pre="infection by 2–3-fold (Mohraz et al., 2018). The prevention and" exact="treatment" post="of GH has always been an urgent problem to"/>
  <result pre="has always been an urgent problem to be solved. HSV-2" exact="infection" post="is a sequential process involving the interaction of multiple"/>
  <result pre="ICP27, ICP22, and ICP47, generally peaks around 2–4 h after" exact="infection" post="(Halford et al., 2001). The immediate early proteins are"/>
  <result pre="ICP8, and viral thymidine kinase, peaks around 5–7 h after" exact="infection" post="(Costa et al., 1997). Expression of late gene transcripts"/>
  <result pre="gK, VP16, VP5, and vhs peaks around 12–15 h after" exact="infection" post="(Sampath and Deluca, 2008). The nucleocapsid is comprised of"/>
  <result pre="2018), and have little impact on latent and recurrent viral" exact="infection" post="(Akhrameyeva et al., 2011). Therefore, the development of drugs"/>
  <result pre="of drugs acting at the adhesion, penetration, release, and intercellular" exact="infection" post="stages of HSV-2 has become an important research goal."/>
  <result pre="by clinical practice. It plays a vital role in the" exact="treatment" post="of epidemic infection of severe acute respiratory syndrome coronavirus"/>
  <result pre="It plays a vital role in the treatment of epidemic" exact="infection" post="of severe acute respiratory syndrome coronavirus (SARS-CoV) and influenza"/>
  <result pre="sore&quot; is oftenly cited by most doctors as the TCM" exact="diagnosis" post="of GH (Feng and Zhu, 2015). Symptoms of GH"/>
  <result pre="external application of Chinese herbs or Chinese medicine compounds. The" exact="treatment" post="strategies was adjusted at different stages of the disease."/>
  <result pre="strategies was adjusted at different stages of the disease. The" exact="treatment" post="at early stage of GH is to eliminate pathogenic"/>
  <result pre="is to eliminate pathogenic factors. When healing is delayed, the" exact="treatment" post="is to both strengthen body resistance and eliminate evil."/>
  <result pre="the incubation period or repeated attacks of GH, the main" exact="treatment" post="is to strengthen healthy energy. On the basis of"/>
  <result pre="of 1.0 mL/min and a column temperature 26 °C. The" exact="detection" post="wavelength was set at 230 nm. Twenty microliters of"/>
  <result pre="obtained from LI-COR Biosciences (USA). 2.4 Time course of HSV-2" exact="infection" post="of VK2/E6E7 at room temperature VK2/E6E7 were seeded in"/>
  <result pre="and dictamnine (see Fig. 1). 3.2 Time course of HSV-2" exact="infection" post="of VK2/E6E7 at room temperature and using temperature control"/>
  <result pre="viability in HSV-2 adhesion group, HSV-2 penetration group and HSV-2" exact="infection" post="24 h group were significantly decreased compared with control"/>
  <result pre="pH 3.0, and neutralized using PBS, pH 11.0. In HSV-2" exact="infection" post="24 h group, VK2/E6E7 and HSV-2 solution were co-incubated"/>
  <result pre="V2 stands for HSV-2 penetration group, V stands for HSV-2" exact="infection" post="24 h group. **P &amp;lt; 0.01 versus control group,"/>
  <result pre="gD, VP16, ICP5, and ICP4 were significantly increased in HSV-2" exact="infection" post="24 h group (P &amp;lt; 0.001). As shown in"/>
  <result pre="changes in cell morphology. 3.4 Effect of JZ-1 on HSV-2" exact="infection" post="of VK2/E6E7 As shown in Fig. 4 A and"/>
  <result pre="(B) Antiviral effects of different concentrations of JZ-1 against HSV-2" exact="infection" post="by MTT assay. (C) Effect of JZ-1 on morphology"/>
  <result pre="× 400). (E) Ultrastructural observation of JZ-1 intervention on HSV-2" exact="infection" post="of VK2/E6E7. VK2/E6E7, HSV-2 solution, and drugs (or medium)"/>
  <result pre="for different concentrations of JZ-1 group, JV sands for JZ-1" exact="treatment" post="group, PV stands for penciclovir treatment group, BV stands"/>
  <result pre="JV sands for JZ-1 treatment group, PV stands for penciclovir" exact="treatment" post="group, BV stands for berberine treatment group. Data are"/>
  <result pre="PV stands for penciclovir treatment group, BV stands for berberine" exact="treatment" post="group. Data are expressed as mean±SEM for n ="/>
  <result pre="in HSV-2 alone group was minimal at 6 h after" exact="infection" post="and gradually increased with time. Expression of gD in"/>
  <result pre="and TEM indicates that JZ-1 and penciclovir could inhibit HSV-2" exact="infection" post="in vitro and reduce damage to cells, while berberine"/>
  <result pre="also demonstrated that JZ-1 and penciclovir could significantly inhibit HSV-2" exact="infection" post="and improve cell viability at treatment of 24 h,"/>
  <result pre="could significantly inhibit HSV-2 infection and improve cell viability at" exact="treatment" post="of 24 h, consistent with the results above. Immunofluorescence"/>
  <result pre="V2 stands for HSV-2 penetration group, JV stands for JZ-1" exact="treatment" post="group, PV stands for penciclovir treatment group, BV stands"/>
  <result pre="JV stands for JZ-1 treatment group, PV stands for penciclovir" exact="treatment" post="group, BV stands for berberine treatment group.*P &amp;lt; 0.05"/>
  <result pre="PV stands for penciclovir treatment group, BV stands for berberine" exact="treatment" post="group.*P &amp;lt; 0.05 versus V group,**P &amp;lt; 0.01 versus"/>
  <result pre="HVEM, Nectin-1, and Nectin-2 among the control group, the HSV-2" exact="infection" post="group and the treatment groups as showed by Western"/>
  <result pre="among the control group, the HSV-2 infection group and the" exact="treatment" post="groups as showed by Western blot, suggesting that HSV-2"/>
  <result pre="treatment groups as showed by Western blot, suggesting that HSV-2" exact="infection" post="and drug treatment may not alter the expression level"/>
  <result pre="showed by Western blot, suggesting that HSV-2 infection and drug" exact="treatment" post="may not alter the expression level of host cell"/>
  <result pre="S. nigrum L. is wildly used in TCM for the" exact="treatment" post="of a wide range of diseases including some eye"/>
  <result pre="detoxication, and easing joint movement. It is testified in clinic" exact="treatment" post="that it can cure syphilitic poisoned sores, morbid leucorrhea,"/>
  <result pre="detoxication. It has been wildly used in TCM for the" exact="treatment" post="of rheumatism, itching, bleeding, chronic hepatitis, jaundice, and skin"/>
  <result pre="showed that only JZ-1 had an antiviral effect at the" exact="treatment" post="of 6 h. Since the late gene transcription products"/>
  <result pre="other viral structural proteins, are produced significantly 12–15 h after" exact="infection" post="(Ibáñez et al., 2018; Su et al., 2017), the"/>
  <result pre="the gD observed in host cells at 6 h of" exact="infection" post="was mostly derived from the original virons that infected"/>
  <result pre="Both penciclovir and JZ-1 showed apparent antiviral effects at the" exact="treatment" post="of 12 h, 18 h, and 24 h according"/>
  <result pre="observations and analysis of cell survival after 24 h of" exact="infection" post="showed that cell survival rate and cell morphology (including"/>
  <result pre="antiviral effect of JZ-1 was superior to penciclovir at the" exact="treatment" post="of 12 h, 18 h, and 24 h, indicating"/>
  <result pre="al., 2016a). gB and gD are essential for mediating the" exact="infection" post="of HSV-2 to host cells (Fujimoto et al., 2019)."/>
  <result pre="is not only the key factor of HSV-2 lytic mode" exact="infection" post="but also critical for the virus to be reactivated"/>
  <result pre="of VP16 expression indicates that JZ-1 can not only anti-HSV-2" exact="infection" post="of VK2/E6E7, but also interfere with HSV-2 intracellular replication"/>
  <result pre="HVEM, Nectin-1, and Nectin-2 between the control group, the virus" exact="infection" post="group and the treatment group, suggesting that viral infection"/>
  <result pre="between the control group, the virus infection group and the" exact="treatment" post="group, suggesting that viral infection and drug treatments did"/>
  <result pre="virus infection group and the treatment group, suggesting that viral" exact="infection" post="and drug treatments did not alter the expression level"/>
  <result pre="of JZ-1 (Bright et al., 2012). At the same time," exact="infection" post="of HSV-2 to host cells are cross-regulated by multiple"/>
  <result pre="also provided new ideas of TCM in the prevention and" exact="treatment" post="of viral infectious diseases. Authors ‘contribution The head of"/>
  <result pre="herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2" exact="infection" post="in miceJ. Virol.8520115036504721389121 BenzekriR.BouslamaL.PapettiA.HammamiM.SmaouiA.LimamF.Anti HSV-2 activity of Peganum harmala"/>
  <result pre="miceJ. Virol.8520115036504721389121 BenzekriR.BouslamaL.PapettiA.HammamiM.SmaouiA.LimamF.Anti HSV-2 activity of Peganum harmala (L.) and" exact="isolation" post="of the active compoundMicrob. Pathog.114201829129829223449 BrightH.PerezD.L.ChristyC.CockleP.EylesJ.E.HammondD.KhodaiT.LangS.WestK.LoudonP.T.The efficacy of HSV-2"/>
  <result pre="virus type 2 in vitro and in vivoViruses102018119 DavisW.B.OakesJ.E.TaylorJ.A.Effect of" exact="treatment" post="with 5-ethyl-2’-deoxyuridine on herpes simplex virus encephalitis in normal"/>
  <result pre="viruses in vitroFront. Microbiol.92018240630386309 JiangJ.J.XieY.M.WangY.Y.YuanL.I.ZhangY.L.SunS.L.WangS.ZhuY.Wen-ShengQ.I.ChenX.Study of Jinye Baidu granule in" exact="treatment" post="of wind-warmth lung heat disease (heat in lung-wei pattern)"/>
  <result pre="LIS.XuJ.JinS.-F.Effect of Yihuang decoction combined with chitosan membrane in the" exact="treatment" post="of cervical HPV infectionChinese. Guangming J. Chin. Med.201734543457 LiW.WangX.-H.LuoZ.LiuL.-F.YanC.YanC.-Y.ChenG.-D.GaoH.DuanW.-J.KuriharaH.LiY.-F.HeR.-R.Traditional"/>
  <result pre="Res.28201474675224499319 MohrazM.AghakhaniA.Moayedi-NiaS.BanifazlM.JanbakhshA.MamishiS.KaramiA.BavandA.MirzapourP.RamezaniA.No role of herpes simplex virus type 2 (HSV-2)" exact="infection" post="on HIV progression in naïve HIV patientsIran. Biomed. J.22201812312828688377"/>
  <result pre="Rev.37201714917927518199 SmithC.A.SchafferP.A.Mutants defective in herpes simplex virus type 2 ICP4:" exact="isolation" post="and preliminary characterizationJ. Virol.611987109210973029403 SuA.QiuM.LiY.XuW.SongS.WangX.SongH.ZhengN.WuZ.BX-795 inhibits HSV-1 and HSV-2"/>
  <result pre="and pharmacokinetic review. Evid. Based complementAltern. Med.2019201945 TaoP.Strategies for antiviral" exact="screening" post="targeting early steps of virus infectionVirol. Sin.25201028129320960301 Vilhelmova-IlievaN.JacquetR.QuideauS.GalabovA.S.Ellagitannins as"/>
  <result pre="ChineseJilin J. Chin. Med.2019726729 XinJ.TanT.-H.Clinical observation on treating female mycoplasma" exact="infection" post="with the Yihuang decoction plus doxycycline. In ChineseClin. J."/>
 </snippets>
</snippetsTree>
